Here is a hint look at EMEA process and why Genta is concentrating there first. If you have been investing in Biotechs for twenty years I should not have to point this out. Second note holders converting their notes is going to have no affect on burn rate. Genta can not spare the money to pay the interest in cash. Pretty obvious you need to do more DD.